Original disclosure @ IDBI website
Updated in EWS Nov 18, 2022
Disclosed by Bank Sep 30, 2022
Can you contribute information about this project?
Contact the EWS Team
The purpose of the operation with Fundacao Butantan ("Client" or "Butantan") is to finance the construction of two new pharmaceutical manufacturing and processing units: i) the Egg-based Vaccine Research Center ("CPVO II"), which consists of an Influenza vaccine manufacturing plant; and ii) the Final Processing Center for Immunobiologicals ("CPFI"), which consists of a plant for formulating, filling, lyophilizing, crimping, labeling, and packaging pharmaceutical products ("Project").
The operation will be structured in the form of a loan, with a final term of 10 years, including a 3-year grace period. The project will be developed in the City of Sao Paulo, Brazil, at the same location where Fundacao Butantan currently operates.
Addendum: On November 7, a revised version is uploaded for the Environmental and Social Impact Study.
ACCESS TO INFORMATION
You can submit a request for information disclosure at:
ACCOUNTABILITY MECHANISM OF IDB / IDB INVEST
The Independent Consultation and Investigation Mechanism (MICI) is the independent complaint mechanism and fact-finding body for people who have been or are likely to be adversely affected by an Inter-American Development Bank (IDB) or Inter-American Investment Corporation (IDB Invest)-funded project. If you submit a complaint to MICI, they may assist you in addressing the problems you raised through a dispute-resolution process with those implementing the project and/or through an investigation to assess whether the IDB or IDB Invest is following its own policies for preventing or mitigating harm to people or the environment. You can submit a complaint by sending an email to MICI@iadb.org. You can learn more about the MICI and how to file a complaint at http://www.iadb.org/en/mici/mici,1752.html (in English) or http://www.iadb.org/es/mici/mici,1752.html (Spanish).